TRIPLEX HBV/HCV/HIV RT-PCR
- UID
- MFG/IVD/2023/000086_e36978cb511a9e7a73dc638bdaa706e6_3e8fa4d4151da884c82fc2b052d9c703
- Device class
- Class D
- License holder
- Promea Therapeutics Private Limited
- Approving authority
- CDSCO, Zonal office, Hyderabad
- Product information
- The Triplex HBV/HCV/HIV RT-PCR kit is intended for the qualitative detection of nucleic acid from HBV, HCV and HIV in plasma samples collected from individuals for screening purpose.
TRIPLEX HBV/HCV/HIV RT-PCR is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/IVD/2023/000086_e36978cb511a9e7a73dc638bdaa706e6_3e8fa4d4151da884c82fc2b052d9c703. The license holder is Promea Therapeutics Private Limited, and it is classified as Device Class Class D. The approving authority is CDSCO, Zonal office, Hyderabad.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.